Invesco’s Nymox Pharmaceutical Corp NYMX Stock Holding History

Invesco’s Portfolio NYMX Stock Details NYMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-28,450	Closed	-$63K	–	4064
2021 Q1	$63K	Buy	28,450 +1,201	+4%	+$3.17K	﹤0.01%	3814
2020 Q4	$68K	Buy	+27,249	New	+$60.2K	﹤0.01%	3703

Other funds holding NYMX

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TEE

Tibra Equities Europe London, United Kingdom $90.4M AUM 37.81% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

LSA

Leonteq Securities AG Zurich, Switzerland $2.91B AUM 56.5% 1-Year Est. Return

Webster Bank Waterbury, Connecticut $1.15B AUM 23.08% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ECM

ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return

Invesco's NYMX Position: Q2 2021 in Review

Invesco sold out of Nymox Pharmaceutical Corp (NYMX) in Q2 2021, closing a stake of 28,450 shares — an estimated $63K sold.

Invesco first reported a position in NYMX in Q4 2020 and held it in 2 quarters. The position peaked at $68K in Q4 2020. 51 funds tracked by Wall St. Rank hold NYMX as of Q2 2021.

Invesco reported no remaining Nymox Pharmaceutical Corp position as of Q2 2021 after selling out during the quarter.
Invesco sold 28,450 Nymox Pharmaceutical Corp shares in Q2 2021, an estimated $63K.
Invesco first reported a position in Nymox Pharmaceutical Corp in Q4 2020 and held it in 2 quarters.
Invesco's Nymox Pharmaceutical Corp position peaked at $68K in Q4 2020.
51 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q2 2021.

Based on Invesco's 13F filing for Q2 2021, filed 17 Aug 2021.